Dr Ash Ramzan, our principal consultant, recently took part in a Biosimilar Experts Roundtable Discussion hosted by biosimilar expert Dr Fiona Greer and joined...
Drug-device combination products are increasingly prevalent in modern medicine, and include a range of products such as medical devices that have been impregnated or...
As with many things post-Brexit, conformity marking of medical devices and IVDs has become much more complex for those looking to enter the market...
Woodley BioReg delivered successful scientific advice to accelerate biosimilars development and the registration of a biological product. Our client was based in the EU...
This is the fourth and final blog in our series on medicinal cannabis. To view the others, click here. Legal framework In the UK, there...
This is the third blog in our medicinal cannabis series. You can view the first and second article here to receive a deeper background and understanding...
Second in our medicinal cannabis blog series, this article explores the regulatory background of medicinal cannabis in the EU and the UK. If you...
One of the most commonly proscribed drugs used throughout the world is cannabis. The drug has provoked both political discussion and public opinion. However...